Burden of Illness Associated with Tenosynovial Giant Cell Tumors

This publication has 24 references indexed in Scilit:

• Increased Frequency and Costs of Ambulatory Medical Care Utilization Prior to the Diagnosis of Rheumatoid Arthritis: A National Population‐Based Study
  Arthritis Care & Research, 2013
• Association of Patient-Centered Outcomes With Patient-Reported and ICD-9-Based Morbidity Measures
  The Annals of Family Medicine, 2012
• Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis
  Cancer, 2011
• Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis
  Current Opinion in Oncology, 2011
• Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
  American Journal of Epidemiology, 2011
• Giant Cell Tumor of Tendon Sheath: Case Series and Review of Literature
  Journal of Hand and Microsurgery, 2010
• Outcomes after Excision of Pigmented Villonodular Synovitis of the Knee
  Clinical Orthopaedics and Related Research, 2009
• Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT)
  Annals of Oncology, 2008
• Outcome following radiation treatment for high-risk pigmented villonodular synovitis
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
• Pigmented Villonodular Synovitis and Tenosynovitis
  Medicine, 1980